showed that ovarian cancer models expressing MUC1, after anti-PD-L1 antibody treatment, exhibited increased T cell infiltration in tumors and extended survival, indicating MUC1’s potential in ovarian cancer immunotherapy (143). The gene discussed is CD274; the disease is ovarian cancer.